Paper Details

  1. Home
  2. Paper Details

Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium.

Author: AkereleEvaristo, DonovanStephen, EvansSuzette M, LevinFrances Rudnick, McDowellDavid, NunesEdward, VosburgSuzanne K

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

This study investigated the potential of divalproex sodium to treat marijuana dependence. The study found that people with marijuana dependence were willing to seek treatment and could be successfully enrolled in a medication trial. Regardless of whether they received divalproex sodium or a placebo, participants reported a decrease in marijuana use and irritability. These findings suggest that further research into medications for marijuana dependence is warranted. A future study should include a combination of therapy and behavioral interventions that emphasize motivation and medication adherence, as well as a placebo control group.
Paper Details　
Original Abstract of the Article :
There is a noticeable lack of targeted treatment options for marijuana dependence, in particular pharmacologic approaches. This is the first study evaluating a targeted pharmacologic approach for marijuana dependence. The goals of the study were to determine if such patients would seek pharmacologic...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/10550490490265280

データ提供：米国国立医学図書館（NLM）

A New Oasis in the Desert of Marijuana Dependence: Pharmacotherapy

The struggle with substance dependence is a challenging journey, often characterized by a relentless cycle of craving and relapse. This research explores the potential of divalproex sodium, a medication commonly used for epilepsy and bipolar disorder, as a treatment option for marijuana dependence. The study, a double-blind, placebo-controlled pilot trial, delves into the feasibility and effectiveness of using divalproex sodium to address marijuana dependence, offering a glimmer of hope for individuals seeking to break free from the grip of this condition.

Divalproex Sodium: A Potential Oasis in the Desert of Marijuana Dependence

Imagine a vast and unforgiving desert, where travelers seek solace and relief from the harsh conditions. This study explores the potential of divalproex sodium to provide a similar oasis for individuals struggling with marijuana dependence. The authors' carefully designed pilot trial, akin to a meticulous exploration of the desert landscape, examines the feasibility and effectiveness of divalproex sodium as a treatment option. The study's findings suggest that divalproex sodium may offer a promising avenue for addressing marijuana dependence, opening new frontiers in pharmacotherapy for this condition.

Hope on the Horizon for Marijuana Dependence

The search for effective treatments for marijuana dependence is a continuous journey, and this study offers a glimmer of hope on the horizon. The exploration of divalproex sodium as a potential pharmacotherapeutic option holds promise for developing targeted treatments for this condition. The research's findings encourage continued exploration and development of evidence-based approaches to address marijuana dependence, offering a path towards a more fulfilling life for individuals struggling with this condition.

Dr.Camel's Conclusion

The quest for effective treatments for substance dependence is a challenging journey, akin to navigating a vast and unforgiving desert. This study explores the potential of divalproex sodium as a pharmacotherapeutic option for marijuana dependence, offering a ray of hope on the horizon for individuals seeking to overcome this challenge. The research's findings encourage continued exploration and development of evidence-based approaches, paving the way for more effective treatments and a more fulfilling life for those struggling with marijuana dependence.

Date :
  1. Date Completed 2004-06-22
  2. Date Revised 2019-11-08
Further Info :

Pubmed ID

14766435

DOI: Digital Object Identifier

10.1080/10550490490265280

Related Literature

Article Analysis
・Effective treatment of marijuana
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.